[HTML][HTML] Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA Orsi, JS Biedermann, MJHA Kruip… - Journal of Thrombosis …, 2019 - Elsevier
Essentials• The role of statins in hemostasis and venous thromboembolism (VTE)
prophylaxis is not clear.• This trial assessed whether rosuvastatin use affects thrombin …
prophylaxis is not clear.• This trial assessed whether rosuvastatin use affects thrombin …
[PDF][PDF] Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA ORSI, JS BIEDERMANN, MJHA KRUIP… - Journal of Thrombosis …, 2018 - core.ac.uk
Background: Statin therapy could form an alternative prophylactic treatment for venous
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
FA Orsi, JS Biedermann, M Kruip… - … of Thrombosis and …, 2019 - europepmc.org
Background Statin therapy could form an alternative prophylactic treatment for venous
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA Orsi, J Biedermann, M Kruip… - Journal of Thrombosis …, 2019 - repub.eur.nl
Background Statin therapy could form an alternative prophylactic treatment for venous
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA Orsi, JS Biedermann, MJHA Kruip, FJ van der Meer… - 2019 - pubmed.ncbi.nlm.nih.gov
Essentials The role of statins in hemostasis and venous thromboembolism (VTE)
prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin …
prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin …
[PDF][PDF] Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA ORSI, JS BIEDERMANN, MJHA KRUIP… - Journal of Thrombosis …, 2018 - pure.eur.nl
Background: Statin therapy could form an alternative prophylactic treatment for venous
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA Orsi, JS Biedermann, MJHA Kruip… - Journal of Thrombosis …, 2019 - bv.fapesp.br
Background Statin therapy could form an alternative prophylactic treatment for venous
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
[HTML][HTML] Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA Orsi, JS Biedermann, MJHA Kruip… - Journal of Thrombosis …, 2019 - jthjournal.org
Unlabelled Box• The role of statins in hemostasis and venous thromboembolism (VTE)
prophylaxis is not clear.• This trial assessed whether rosuvastatin use affects thrombin …
prophylaxis is not clear.• This trial assessed whether rosuvastatin use affects thrombin …
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA Orsi, JS Biedermann, MJHA Kruip… - … of Thrombosis and …, 2019 - Wiley Online Library
Essentials The role of statins in hemostasis and venous thromboembolism (VTE)
prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin …
prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin …
[HTML][HTML] Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA Orsi, JS Biedermann, MJHA Kruip… - … of Thrombosis and …, 2019 - ncbi.nlm.nih.gov
Background Statin therapy could form an alternative prophylactic treatment for venous
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …
thromboembolism (VTE) if statins are proven to downregulate hemostasis and prevent …